Alkermes plc

Irlande

Commandez votre montre hebdomadaire Alkermes plc
Quantité totale PI 9
Quantité totale incluant filiales 407 (+ 401 pour les filiales)
Rang # Quantité totale PI 178 881
Note d'activité PI 1,5/5.0    5
Rang # Activité PI 201 659
Activité incl filiales 2,7/5.0    152
Symbole boursier ALKS (nasdaq)
ISIN USG017671052
Capitalisation 5,099M  (USD)
Industrie Biotechnology
Secteur Healthcare

Brevets

Marques

9 0
0 0
0 0
0
 
Dernier brevet 2024 - Immunostimulatory agents in comb...
Premier brevet 2019 - Ligands modified by circular per...

Filiales

6 subsidiaries with IP (321 patents, 80 trademarks)

2 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Derniers inventions, produits et services

2023 Invention Immunostimulatory agents in combination with angiogenesis inhibitors. The invention provides com...
2021 Invention Il-2 fusion polypeptide compositions and methods of making and using the same. Provided herein a...
Invention Immunostimulatory agents in combination with angiogenesis inhibitors. The invention provides comp...
Invention Methods of purification. Provided herein are methods of purifying polypeptides comprising a circ...
2020 Invention Immunomodulatory il-2 agents in combination with immune checkpoint inhibitors. The invention prov...
Invention Compositions and methods for subcutaneous administration of cancer immunotherapy. reg) expansion ...
Invention Compositions and methods for cancer immunotherapy. The invention provides compositions and impro...
2019 Invention Ligands modified by circular permutation as agonists and antagonists. The present invention prov...